Association of tamoxifen resistance and lipid reprogramming in breast cancer

BACKGROUND: Tamoxifen treatment of estrogen receptor (ER)-positive breast cancer reduces mortality by 31%. However, over half of advanced ER-positive breast cancers are intrinsically resistant to tamoxifen and about 40% will acquire the resistance during the treatment. METHODS: In order to explore m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Hultsch, Susanne, Kankainen, Matti, Paavolainen, Lassi, Kovanen, Ruusu-Maaria, Ikonen, Elina, Kangaspeska, Sara, Pietiäinen, Vilja, Kallioniemi, Olli
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6109356/
https://ncbi.nlm.nih.gov/pubmed/30143015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4757-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars